2 December 2013 - Medicines Australia’s submission to the National Commission of Audit, released today, shows that the key issue for the Pharmaceutical Benefits Scheme is ensuring it is fit for purpose for listing new medicines.

“The bottom line is that a lot of the work to make the PBS financially secure in the long term has already been done,” said Medicines Australia Chief Executive, Dr Brendan Shaw said today.

“The industry has worked with successive governments over the last decade to ensure that the PBS is financially sustainable.

For more details, go to: http://medicinesaustralia.com.au/2013/12/02/commission-of-audit-must-look-forward-on-pbs/